Clinical Trials Directory

Trials / Completed

CompletedNCT00800475

Bioequivalence Study Between Two Oral Formulations of Gemfibrozil Tablets

A Relative Bioequivalence Study of 600 mg Gemfibrozil Tablets Under Fasting Conditions

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Blu Caribe · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether two oral formulations of Gemfibrozil Tablets are bioequivalent.

Conditions

Interventions

TypeNameDescription
DRUGGemfibrozil Tablets

Timeline

Start date
2005-07-01
Primary completion
2005-07-01
Completion
2005-09-01
First posted
2008-12-02
Last updated
2013-08-13

Source: ClinicalTrials.gov record NCT00800475. Inclusion in this directory is not an endorsement.

Bioequivalence Study Between Two Oral Formulations of Gemfibrozil Tablets (NCT00800475) · Clinical Trials Directory